Meyer Isuzu, McGwin Gerald, Swain Thomas A, Alvarez Mitchell D, Ellington David R, Richter Holly E
Division of Urogynecology and Pelvic Reconstructive Surgery, University of Alabama at Birmingham, Birmingham, AL.
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL.
J Minim Invasive Gynecol. 2016 May-Jun;23(4):614-21. doi: 10.1016/j.jmig.2016.02.014. Epub 2016 Feb 23.
To report long-term objectives and subjective outcomes in women who underwent prolapse surgery with a synthetic graft augmentation.
Retrospective analysis (Canadian Task Force classification II-3).
University hospital in the southeastern United States.
Women with symptomatic pelvic organ prolapse who underwent transvaginal graft augmentation using the Prolift mesh system between July 2006 and December 2008 for a minimum 5-year follow-up.
Subjects completed the Pelvic Floor Distress Inventory (PFDI-20), the Pelvic Floor Impact Questionnaire (PFIQ-7), the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ), and the Patient Satisfaction Questionnaire. Subjects also underwent postoperative physical examination with Pelvic Organ Prolapse Quantification (POP-Q) and vaginal pain/stricture assessment. Long-term postoperative findings were compared with preoperative baseline data.
Of 208 eligible subjects, 70 completed the questionnaires only, and 48 of these 70 provided both postoperative examination and questionnaire data. The mean duration of follow-up was 7.0 ± 0.7 years (range, 5.8-8.1 years). POP-Q measurements of Ba (point B anterior), Bp (B posterior), C (cervix), GH (genital hiatus), PB (perineal body), and overall pelvic organ prolapse stage were significantly improved (all p < .001 except for PB, p = .006). PFIQ-7 (total, Urinary Impact Questionnaire, and Pelvic Organ Prolapse Impact Questionnaire) and PFDI-20 (total, Urinary Distress Inventory, and Pelvic Organ Prolapse Distress Inventory) scores significantly improved (all p < .001). No differences were noted in the colorectal-anal subscales (Colorectal-Anal Impact Questionnaire and Colorectal-Anal Distress Inventory) and PISQ scores at >5-year follow-up (all p > .05). Satisfaction rates were 15.7% for not at all, 35.7% for somewhat, and 48.6% for completely satisfied. Complications included graft exposure (n = 3; 6%) and dyspareunia (n = 25; 36%).
Women undergoing transvaginal prolapse surgery using a synthetic graft continue to have positive objective and subjective outcomes, leading to significantly improved quality of life at a minimum 5-year follow-up.
报告接受合成补片增强盆底脱垂手术的女性的长期目标和主观结果。
回顾性分析(加拿大工作组分类II-3)。
美国东南部的大学医院。
2006年7月至2008年12月期间接受经阴道使用Prolift补片系统进行补片增强手术治疗有症状盆腔器官脱垂的女性,进行至少5年的随访。
受试者完成盆底功能障碍量表(PFDI-20)、盆底功能影响问卷(PFIQ-7)、盆腔器官脱垂/尿失禁性功能问卷(PISQ)和患者满意度问卷。受试者还接受术后体格检查,包括盆腔器官脱垂定量评估(POP-Q)和阴道疼痛/狭窄评估。将术后长期结果与术前基线数据进行比较。
208名符合条件的受试者中,70名仅完成问卷,这70名中的48名同时提供了术后检查和问卷数据。平均随访时间为7.0±0.7年(范围5.8 - 8.1年)。Ba(前位B点)、Bp(后位B点)、C(宫颈)、GH(生殖裂孔)、PB(会阴体)的POP-Q测量值以及总体盆腔器官脱垂分期均有显著改善(除PB外,所有p <.001,PB的p = 0.006)。PFIQ-7(总分、尿失禁影响问卷和盆腔器官脱垂影响问卷)和PFDI-20(总分、尿失禁量表和盆腔器官脱垂量表)得分显著改善(所有p <.001)。在5年以上随访时,结直肠-肛门分量表(结直肠-肛门影响问卷和结直肠-肛门量表)和PISQ得分无差异(所有p >.05)。满意度方面,完全不满意为15.7%,有点满意为35.7%,完全满意为48.6%。并发症包括补片暴露(n = 3;6%)和性交困难(n = 25;36%)。
接受经阴道使用合成补片的盆底脱垂手术的女性在至少5年的随访中,客观和主观结果持续呈阳性,生活质量显著改善。